Organon Acquired | Healthcare M&A Deal

Sun Pharmaceutical Industries has acquired Organon, a pharmacy business in New Jersey, for $12 billion. Organon & Co is a women’s healthcare and specialty medicines company with branded products and established distribution, which supports Sun’s pharmacy acquisition strategy in the US market. The Organon acquisition fits Sun’s healthcare M&A push to move beyond generics and expand into higher-value biologics and specialty segments while strengthening presence in Jersey City. Reported as a merger acquisition and still rumoured, the deal is positioned as a strategic, large-cap platform-style move, with deal discussions focused on value-chain expansion and an expected close subject to regulatory approvals.